CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

coronavac

VaccineexperimentalCOVID-19

Clinical trial activity

27 trials · 28 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
15
Phase 3
9
Phase 4
5

Earliest trial started Sep 14, 2020 (NCT04582344)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • SARS-CoV-2Immunity, active

    SARS-CoV-2 immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05683561Phase 3Jan 25, 2023Sinocelltech Ltd.
NCT05428592Phase 3Dec 31, 2022Government of China
NCT05593042Phase 2Oct 31, 2022China National Pharmaceutical Group, Pontificia Universidad Catolica de Chile
NCT05918939Early Phase 1 (Phase 1)Sep 5, 2022Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT05583357Early Phase 1 (Phase 1)Aug 15, 2022Livzon Pharmaceutical Group Inc.
NCT05508477Phase 3Jun 28, 2022Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT05188677Phase 3Jun 13, 2022Clover Biopharmaceuticals
NCT05381350Phase 3Jun 1, 2022Government of China, Sinovac Biotech Co., Ltd
NCT05897190Phase 1May 16, 2022Argorna Pharmaceuticals Co., LTD
NCT05928455Early Phase 1 (Phase 1)May 14, 2022Government of China, North Sichuan Medical University
NCT05303584Phase 4Apr 23, 2022Government of China
NCT05226429Phase 1/Phase 2 (Phase 2)Feb 8, 2022Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT05230940Phase 2Jan 15, 2022Government of Turkey
NCT05087368Phase 2Dec 1, 2021Bill and Melinda Gates Foundation, D'Or Institute for Research and Education, Instituto de Medicina Integral Professor Fernando Figueira, University of Oxford
NCT05668065Phase 3Nov 22, 2021Institut Pasteur
NCT05057169Phase 4Nov 18, 2021The University of Hong Kong
NCT05077176Phase 3Oct 8, 2021Government of Turkey
NCT04979949Phase 2Jul 12, 2021Government of Turkey
NCT04942405Phase 3Jun 21, 2021Government of Turkey
NCT04775069Phase 4May 21, 2021Humanity & Health Research Centre
Showing 20 of 27 trials
Page 1 / 2

Organizations

Research & Development (28)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of TurkeyGovernment5522020
Government of ChinaGovernment4332022
Airlangga UniversityAcademic/Hospital3032022
Biotis Pharmaceuticals, IndonesiaFor profit3032022
Dr. Soetomo General HospitalAcademic/Hospital3332022
Government of IndonesiaGovernment3032022
Cigli Regional Training HospitalAcademic/Hospital2012021
Izmir Bakircay UniversityAcademic/Hospital2212021
Muğla Sıtkı Koçman UniversityAcademic/Hospital2012021
The University of Hong KongAcademic/Hospital2222021
Argorna Pharmaceuticals Co., LTDFor profit1112022
Bill and Melinda Gates FoundationAcademic/Hospital1012021
China National Pharmaceutical GroupFor profit1012022
Clover BiopharmaceuticalsFor profit1112022
D'Or Institute for Research and EducationAcademic/Hospital1112021
Hospital do Rim e HipertensãoAcademic/Hospital1112021
Humanity & Health Research CentreAcademic/Hospital1112021
Instituto de Medicina Integral Professor Fernando FigueiraAcademic/Hospital1012021
Institut PasteurAcademic/Hospital1112021
Livzon Pharmaceutical Group Inc.For profit1112022
28 organizations
Page 1 / 2